Novadaq Technologies of Toronto said it has received 510(k) clearance from the U.S. Food and Drug Administration for a labeling revision of its Spy intraoperative imaging system.
The developer said the labeling revision will allow cardiac surgeons greater flexibility for the administration of imaging agents during coronary artery bypass graft (CABG) procedures with Spy, a fluorescence-guided imaging system.
By AuntMinnie.com staff writers
May 9, 2006
Related Reading
Kodak inks service deal with Novadaq, August 4, 2005
Novadaq receives Spy patent, July 12, 2005
Novadaq inks Spy deal with CarboMedics, Kodak, July 5, 2005
Novadaq picks Spy manufacturer, April 19, 2005
Novadaq reports positive results for Spy system, April 12, 2005
Copyright © 2006 AuntMinnie.com